CLOTIAZEPAM: 323 Adverse Event Reports & Safety Profile
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
323
Total FAERS Reports
41 (12.7%)
Deaths Reported
207
Hospitalizations
323
As Primary/Secondary Suspect
47
Life-Threatening
10
Disabilities
First Report: 200610 · Latest Report: 20250830
What Are the Most Common CLOTIAZEPAM Side Effects?
#1 Most Reported
Coma
65 reports (20.1%)
#2 Most Reported
Toxicity to various agents
54 reports (16.7%)
#3 Most Reported
Somnolence
52 reports (16.1%)
All CLOTIAZEPAM Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Coma | 65 | 20.1% | 16 | 46 |
| Toxicity to various agents | 54 | 16.7% | 16 | 34 |
| Somnolence | 52 | 16.1% | 16 | 32 |
| Suicide attempt | 31 | 9.6% | 0 | 29 |
| Fall | 25 | 7.7% | 0 | 21 |
| Poisoning | 24 | 7.4% | 0 | 18 |
| Confusional state | 21 | 6.5% | 13 | 12 |
| Dizziness | 19 | 5.9% | 0 | 15 |
| Hypotension | 19 | 5.9% | 4 | 18 |
| Drug use disorder | 17 | 5.3% | 5 | 4 |
| Intentional overdose | 17 | 5.3% | 0 | 14 |
| Cardio-respiratory arrest | 16 | 5.0% | 16 | 6 |
| Cardiomyopathy | 16 | 5.0% | 16 | 6 |
| Encephalopathy | 16 | 5.0% | 9 | 13 |
| Hepatic cytolysis | 16 | 5.0% | 16 | 6 |
| Myocarditis | 16 | 5.0% | 16 | 6 |
| Overdose | 16 | 5.0% | 9 | 14 |
| Vomiting | 16 | 5.0% | 0 | 11 |
| Hyperglycaemia | 15 | 4.6% | 14 | 7 |
| Hepatocellular injury | 14 | 4.3% | 0 | 12 |
Who Reports CLOTIAZEPAM Side Effects? Age & Gender Data
Gender: 59.2% female, 40.8% male. Average age: 50.5 years. Most reports from: FR. View detailed demographics →
Is CLOTIAZEPAM Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2006 | 5 | 5 | 0 |
| 2009 | 6 | 1 | 0 |
| 2012 | 9 | 5 | 4 |
| 2013 | 4 | 0 | 3 |
| 2014 | 5 | 0 | 5 |
| 2015 | 6 | 0 | 5 |
| 2016 | 39 | 10 | 33 |
| 2017 | 18 | 1 | 9 |
| 2018 | 32 | 1 | 30 |
| 2019 | 43 | 2 | 28 |
| 2020 | 20 | 1 | 14 |
| 2021 | 7 | 1 | 4 |
| 2022 | 13 | 0 | 4 |
| 2023 | 11 | 0 | 2 |
| 2024 | 8 | 0 | 8 |
| 2025 | 8 | 0 | 7 |
What Is CLOTIAZEPAM Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 133 |
| Anxiety | 38 |
| Suicide attempt | 21 |
| Depression | 15 |
| Agitation | 7 |
| Mixed anxiety and depressive disorder | 6 |
| Seizure | 6 |
| Skin test | 6 |
| Sedation | 5 |
CLOTIAZEPAM vs Alternatives: Which Is Safer?
CLOTIAZEPAM vs CLOTRIMAZOLE
CLOTIAZEPAM vs CLOXACILLIN
CLOTIAZEPAM vs CLOXAZOLAM
CLOTIAZEPAM vs CLOZAPINE
CLOTIAZEPAM vs CLOZARIL
CLOTIAZEPAM vs COAGULATION FACTOR IX HUMAN\COAGULATION FACTOR VII HUMAN\COAGULATION FACTOR X HUMAN\PROTEIN C\PROTEIN S HUMAN\PROTHROMBIN
CLOTIAZEPAM vs COAGULATION FACTOR IX HUMAN\COAGULATION FACTOR VII HUMAN\COAGULATION FACTOR X HUMAN\PROTHROMBIN
CLOTIAZEPAM vs COAGULATION FACTOR IX RECOMBINANT HUMAN
CLOTIAZEPAM vs COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL
CLOTIAZEPAM vs COAGULATION FACTOR VIIA RECOMBINANT HUMAN
Official FDA Label for CLOTIAZEPAM
Official prescribing information from the FDA-approved drug label.